Navigation Links
Kettering Medical Center Acquires Elekta's Versa HD Radiotherapy System
Date:6/3/2013

KETTERING, Ohio, June 3, 2013 /PRNewswire/ -- Kettering Medical Center (Kettering, Ohio) recently began installing Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a wide range of tumors throughout the body. Kettering, a regional center of excellence in stereotactic radiosurgery (SRS) for indications throughout the body, also operates a Leksell Gamma Knife® Perfexion™ system dedicated for SRS in the brain.

According to Douglas Einstein , M.D., Ph.D., Chairman of Radiation Oncology at Kettering, the addition of Versa HD at Kettering Medical Center is the "next evolution" of the clinic's SRS activities over the last several years – which encompasses more than 500 patient treatments – and signifies the center's commitment to providing western Ohio patients with the most advanced techniques available.

Versa HD gives clinicians the flexibility to deliver conventional therapies to treat a broad spectrum of tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision.

"With Versa HD, we believe we can cut total treatment delivery times for our patients in half," Dr. Einstein says. "Due to our extensive experience with SRS, many patients travel to Kettering from a distance to receive our state-of-the-art treatments. This technology will allow more patients to be treated per day. Equally important, shorter treatment times will enhance patient comfort.

"Patients undergoing SRS for lung cancer, for example, may have their arms raised for a 30-minute session and that can be difficult," he adds. "We treat many elderly patients who find the SRS treatment time demanding. The High Dose Rate mode of Versa HD will shorten radiation beam delivery time and potentially improve patient comfort in SRS cases.

"The Versa HD MLC will enable even more conformal treatments that should significantly limit normal tissue exposure and decrease side effects. We can deliver these state-of-the-art techniques with Versa HD and do it such a way that it not only manages their cancer, but also minimizes the impact of treatment on their quality of life."

For more information, visit www.VersaHD.com.

Versa HD is not available for sale or distribution in all markets.

For further information, please contact:
Johan Andersson , Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.andersson@elekta.com  
Time zone: CET: Central European Time

Michelle Joiner , Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical Announces Isolaz 2 Acne System
2. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
3. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
4. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
5. CCS Medical Announces Enhanced Product Formulary
6. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
7. Hair Restoration Center Announces New Female Medical Hair Restoration
8. Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer
9. Medical Device & Implants, LLC to exhibit at MD&M East 2013
10. Holy Name Medical Center Treats Migraine Headaches At Dedicated Center
11. New Research Shows Continuing Medical Education Saves Healthcare Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... COLOGNE, Germany , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to ... http://photos.prnewswire.com/prnh/20160503/362920    Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... ACME Markets, Delaware County ... County Councilman Dave White announced today the ... ACME pharmacies across Delaware County . ... naloxone has saved 26,463 lives nationwide over the past 20 years. ... were authorized to administer naloxone to overdose victims, 244 ...
(Date:5/3/2016)...  While you may be familiar with watching a film or TV show in high definition, ... 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the medical industry,s ... - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology:
(Date:5/5/2016)... Francisco, CA (PRWEB) , ... ... ... intensive lectures and hands-on exercises, the Wharton Seminars for Business Journalists ... a better understanding of key business and economic issues.  This one-day program ...
(Date:5/5/2016)... ... May 05, 2016 , ... Every ... the most heartfelt wishes of these children. The wishes provide hope and ... President and CEO of Make-A-Wish Mississippi, Brent Wilson said, “In 2016, the organization ...
(Date:5/5/2016)... ... ... A recent survey by the Midwest Business Group on Health ... use the free preventive care benefits available to them as part of the Affordable ... public and private employers, MBGH found that only 10% of large employers are aware ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... Pittsburgh-area schoolchildren has found that more than 40 percent of participating fifth-grade students ... , Director of Allergy and Asthma Clinical Research in the Division of Pulmonary, ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... presented a talk highlighting the organization’s successful Care Transitions program at ... The talk was titled “Minimizing Costs in the Post-Acute Environment Through Effective Transitions ...
Breaking Medicine News(10 mins):